Biocompare Spotlights Advances in High-Throughput Screening

Biocompare recently posted an article about high-throughput screening, and Labcyte is featured in the coverage.
Read More


What Science Can Do – Labcyte and AstraZeneca

Our partners at AstraZeneca have a nice profile on their website that talks about our collaboration to create an acoustically loaded mass spec platform, and why they chose to invest in the Labcyte Echo technology. The goal of this work is to expand the utility of mass spectrometry for high-throughput, low-cost, label-free analysis. As you may recall, this product won the SLAS Innovation Award in 2015!
Read More


DDW Magazine Interviews Labcyte Customer Chris Voigt of MIT about Synthetic Biology

The summer issue of Drug Discovery World magazine contains a great interview about synthetic biology with our customer Chris Voigt, a professor of biological engineering at MIT.
Read More

FRIDAY, JUNE 10, 2016

ARTICLE: Individualized Medicine vs. Precision Medicine - DDNews

There are people who will die of cancer this week even though there are drugs that could help them. At the same time, hundreds of patients will undergo cancer chemotherapy that, while debilitating and expensive, will not cure them of their disease.
Read More


WEBINAR: Enabling Cancer Research with Echo Acoustic Liquid Handlers: a PI3K Pathway Case Study

Class I Phosphoinositide 3-kinase (PI3K) proteins have been extensively characterized with respect to their roles in cell proliferation and tumorigenesis, and serve as highly sought-after targets for oncogenic drug development. Labcyte Sr. Applications Scientist Linda Orren will present a series of experiments, all of which target some aspect of the PI3K pathway. These case studies will highlight specifics of assay development and miniaturization that are uniquely enabled by Echo Acoustic Liquid Handlers.
Read More

MONDAY, APRIL 25, 2016

Improved Cell Screening Shows Promise for Leukemia Patients

In an article recently published by In Vivo: Business & Medicine Report, author Mark Ratner writes about the growing use of high-throughput cell screening to identify combinations of therapeutics that are effective against cancer.
Read More

MONDAY, APRIL 25, 2016

Acoustic Liquid Handling Is Making Personalized Medicine a Reality

Labcyte Senior Research Fellow Joe Olechno has a new article in Personalized Medicine in Oncology that offers an informative view of how the Echo® Liquid Handler based on acoustic droplet ejection technology has been instrumental in recent efforts using ex vivo cell assays to inform individualized treatment decisions.
Read More